Applications and limitations of dendrimers in biomedicine AA Chis, C Dobrea, C Morgovan, AM Arseniu, LL Rus, A Butuca, ... Molecules 25 (17), 3982, 2020 | 390 | 2020 |
An overview of the synthesis and antimicrobial, antiprotozoal, and antitumor activity of thiazole and bisthiazole derivatives AM Borcea, I Ionuț, O Crișan, O Oniga Molecules 26 (3), 624, 2021 | 147 | 2021 |
Microbial resistance to antibiotics and effective antibiotherapy AA Chiș, LL Rus, C Morgovan, AM Arseniu, A Frum, AL Vonica-Țincu, ... Biomedicines 10 (5), 1121, 2022 | 57 | 2022 |
Design and Synthesis of Novel 1,3-Thiazole and 2-Hydrazinyl-1,3-Thiazole Derivatives as Anti-Candida Agents: In Vitro Antifungal Screening, Molecular Docking … AI Pricopie, I Ionuț, G Marc, AM Arseniu, L Vlase, A Grozav, LI Găină, ... Molecules 24 (19), 3435, 2019 | 34 | 2019 |
Dendrimers as non-viral vectors in gene-directed enzyme prodrug therapy AA Chis, CM Dobrea, LL Rus, A Frum, C Morgovan, A Butuca, M Totan, ... Molecules 26 (19), 5976, 2021 | 23 | 2021 |
Post-Marketing surveillance of statins—A descriptive analysis of psychiatric adverse reactions in EudraVigilance G Pop, A Farcaș, A Butucă, C Morgovan, AM Arseniu, M Pumnea, ... Pharmaceuticals 15 (12), 1536, 2022 | 21 | 2022 |
A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated Clostridioides difficile Infection Based on Reports from the EudraVigilance Database … BI Vintila, AM Arseniu, C Morgovan, A Butuca, M Sava, V Bîrluțiu, LL Rus, ... Pharmaceuticals 16 (11), 1585, 2023 | 18 | 2023 |
Adverse drug reactions relevant to drug resistance and ineffectiveness associated with meropenem, linezolid, and colistin: an analysis based on spontaneous reports from the … BI Vintila, AM Arseniu, A Butuca, M Sava, V Bîrluțiu, LL Rus, DD Axente, ... Antibiotics 12 (5), 918, 2023 | 17 | 2023 |
Valorization of grape pomace and berries as a new and sustainable dietary supplement: development, characterization, and antioxidant activity testing A Frum, CM Dobrea, LL Rus, LI Virchea, C Morgovan, AA Chis, ... Nutrients 14 (15), 3065, 2022 | 17 | 2022 |
A descriptive analysis of direct oral anticoagulant drugs dosing errors based on spontaneous reports from the EudraVigilance database C Morgovan, CM Dobrea, AA Chis, AM Juncan, AM Arseniu, LL Rus, ... Pharmaceuticals 16 (3), 455, 2023 | 15 | 2023 |
Biopolymeric prodrug systems as potential antineoplastic therapy AA Chis, AM Arseniu, C Morgovan, CM Dobrea, A Frum, AM Juncan, ... Pharmaceutics 14 (9), 1773, 2022 | 14 | 2022 |
A Novel Series of Acylhydrazones as Potential Anti-Candida Agents: Design, Synthesis, Biological Evaluation and In Silico Studies AM Borcea, G Marc, I Ionuț, DC Vodnar, L Vlase, F Gligor, A Pricopie, ... Molecules 24 (1), 184, 2019 | 12 | 2019 |
Safety profile of the trastuzumab-based ADCs: analysis of real-world data registered in EudraVigilance C Morgovan, CM Dobrea, A Butuca, AM Arseniu, A Frum, LL Rus, AA Chis, ... Biomedicines 12 (5), 953, 2024 | 9 | 2024 |
A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and Clostridioides difficile Infection BI Vintila, AM Arseniu, C Morgovan, A Butuca, V Bîrluțiu, CM Dobrea, ... Antibiotics 13 (2), 144, 2024 | 9 | 2024 |
Some Brassicaceae Extracts as Potential Antioxidants and Green Corrosion Inhibitors IMC Ienașcu, A Căta, AA Chis, MN Ştefănuț, P Sfîrloagă, G Rusu, ... Materials 16 (8), 2967, 2023 | 9 | 2023 |
Synthesis and molecular docking study of some new 1, 4-phenylene-bisthiazoles as fungal lanosterol 14α-demethylase inhibitors AM Borcea, G Marc, A Pîrnău, L Vlase, I Ionuț, B Tiperciuc, O Oniga Farmacia 65 (5), 2017 | 9 | 2017 |
Bîrlu t iu V., Rus LL, Ghibu S., Bereanu AS, Roxana Codru I., et al. A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated Clostridioides Difficile Infection … BI Vintila, AM Arseniu, C Morgovan, A Butuca, M Sava Pharmaceuticals 16 (1585), 10.3390, 2023 | 7 | 2023 |
DESIGN AND SYNTHESIS OF SOME NOVEL 1, 2, 4-TRIAZOLE-3-YLMERCAPTO DERIVATIVES AS POTENTIAL ANTI-CANDIDA AGENTS. AI Pricopie, L Vlase, A PÎRNĂU, DC Vodnar, G Marc, C NASTASĂ, ... Farmacia 66 (6), 2018 | 5 | 2018 |
Valorization of grape pomace and berries as a new and sustainable dietary supplement: development, characterization, and antioxidant activity testing. Nutrients. 2022; 14: 3065 A Frum, CM Dobrea, LL Rus, L Virchea, C Morgovan, AA Chis, A Arseniu, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published, 2022 | 4 | 2022 |
An assessment of semaglutide safety based on real world data: from popularity to spontaneous reporting in Eudravigilance database A Butuca, CM Dobrea, AM Arseniu, A Frum, AA Chis, LL Rus, S Ghibu, ... Biomedicines 12 (5), 1124, 2024 | 3 | 2024 |